Genetic and cellular techniques emerge as promising modalities for the treatment of diabetic foot syndrome

Two patient groups potentially to benefit most from these novel methods are patients with critical lower limb ischemia (CLLI) in whom angiosurgery is not indicated, and patients with trophic ulcers resistant to conventional therapy. A series of clinical trials has shown positive effects of transferr...

Full description

Bibliographic Details
Main Authors: Vladimir Iosifovich Konenkov, Vadim Valerievich Klimontov
Format: Article
Language:English
Published: Endocrinology Research Centre 2014-03-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/6340/4318